Open AccessJournal Article
Allergic rhinitis and its impact on asthma
TLDR
The ARIA guidelines were recently updated and recommended that the presence of asthma must be considered in all patients with rhinitis, and that in planning treatment, both should be considered together in terms of efficacy and safety.Abstract:
Allergic rhinitis causes major illness and disability worldwide, but it is still underdiagnosed and undertreated. Allergic rhinitis is a risk factor for both the development and for exacerbations of asthma. Up to 30% of patients with rhinitis suffer from asthma, and the majority of patients with asthma suffer from rhinitis. Measurements of allergic status can help to identify risk factors that cause asthma. Hence, the Allergic Rhinitis and its Impact on Asthma (ARIA) initiative recommends that the presence of asthma must be considered in all patients with rhinitis, and that in planning treatment, both should be considered together in terms of efficacy and safety. Treatment of rhinitis may improve asthma symptoms. Due to new studies and diagnostic techniques the ARIA guidelines, initially formed in 1999, were recently updated. They are intended for specialists, general physicians and health care providers in order to increase the knowledge on allergic rhinitis and its impact on asthma and to provide evidence-based revision on the diagnostic methods, treatments and a stepwise approach to management. There is a need for a collaborative effort of all specialists and primary physicians involved in the treatment of rhinitis and asthma for the proper implementation of the guidelines.read more
Citations
More filters
Journal ArticleDOI
Global strategy for asthma management and prevention: GINA executive summary.
Eric D. Bateman,Suzanne S. Hurd,Peter J. Barnes,Jean Bousquet,Jeffrey M. Drazen,JM FitzGerald,Peter G. Gibson,K. Ohta,Paul M. O'Byrne,Søren Pedersen,Emilio Pizzichini,Sean D. Sullivan,Sally E. Wenzel,Heather J. Zar +13 more
TL;DR: It is reasonable to expect that in most patients with asthma, control of the disease can and should be achieved and maintained, and the Global Initiative for Asthma recommends a change in approach to asthma management, with asthma control, rather than asthma severity, being the focus of treatment decisions.
Journal ArticleDOI
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
Wytske Fokkens,Valerie J. Lund,Joachim Mullol,Claus Bachert,Isam Alobid,Fuad M. Baroody,Noam A. Cohen,Anders Cervin,Richard Douglas,Philippe Gevaert,Christos Georgalas,Herman Goossens,Richard J. Harvey,Peter Hellings,Claire Hopkins,Nick Jones,Guy Joos,Livije Kalogjera,Bob Kern,Marek L. Kowalski,David Price,Herbert Riechelmann,Rodney J. Schlosser,Brent A. Senior,Mike Thomas,Elina Toskala,Richard Louis Voegels,De Yun Wang,Peter-John Wormald +28 more
TL;DR: The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012 and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery.
Journal ArticleDOI
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Jan Brozek,Jean Bousquet,Carlos E. Baena-Cagnani,Sergio Bonini,G. Walter Canonica,Thomas B. Casale,Roy Gerth van Wijk,Ken Ohta,Torsten Zuberbier,Holger J. Schünemann +9 more
TL;DR: These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children and patients are encouraged to use these recommendations in their daily practice and to support their decisions.
Journal ArticleDOI
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
Jan Brozek,Jean Bousquet,Ioana Agache,Arnav Agarwal,Claus Bachert,Sinthia Bosnic-Anticevich,Romina Brignardello-Petersen,G. Walter Canonica,Thomas B. Casale,Niels H. Chavannes,Jaime Correia de Sousa,Alvaro A. Cruz,Carlos A. Cuello-Garcia,Pascal Demoly,Mark S. Dykewicz,Itziar Etxeandia-Ikobaltzeta,Ivan D. Florez,Wytske Fokkens,João Fonseca,Peter Hellings,Ludger Klimek,Sergio Kowalski,Piotr Kuna,Kaja-Triin Laisaar,Désirée Larenas-Linnemann,Karin C. Lødrup Carlsen,Peter J. Manning,Eli O. Meltzer,Joaquim Mullol,Antonella Muraro,Robyn E O'Hehir,Ken Ohta,Petr Panzner,Nikolaos G. Papadopoulos,Hae-Sim Park,Gianni Passalacqua,Ruby Pawankar,David Price,John J. Riva,Yetiani Roldan,Dermot Ryan,Behnam Sadeghirad,Bolesław Samoliński,Peter Schmid-Grendelmeier,Aziz Sheikh,Alkis Togias,Antonio Valero,Arunas Valiulis,Erkka Valovirta,Matthew Ventresca,Dana Wallace,Susan Waserman,Magnus Wickman,Wojtek Wiercioch,Juan José Yepes-Nuñez,Luo Zhang,Yuan Zhang,Mihaela Zidarn,Torsten Zuberbier,Holger J. Schünemann +59 more
TL;DR: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR, addressing the relative merits of using oral H1‐antihistamines, intranasal H1-antihistsamines, IntranasAL corticosteroids, and leukotriene receptor antagonists either alone or in combination.
Journal ArticleDOI
The diagnosis and management of rhinitis: An updated practice parameter
Dana Wallace,Mark S. Dykewicz,David I. Bernstein,Joann Blessing-Moore,Linda Cox,David A. Khan,David M. Lang,Richard A. Nicklas,John Oppenheimer,Jay M. Portnoy,Christopher Randolph,Diane E. Schuller,Sheldon L. Spector,Stephen A. Tilles +13 more
TL;DR: This document incorporated the efforts of many participants, and no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters.
Related Papers (5)
Improving outcomes for asthma patients with allergic rhinitis: the MetaForum conferences
Stephen T. Holgate,David Price +1 more